Psoriasis: open trials in Spain

18 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Futuremeds Spain S.L., Madrid · Grupo Dermatológico y Estético Pedro Jaén S.A, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Vithas Parque San Antonio, Malaga · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Viamed Santa Ángela de la Cruz, Sevilla
Registry updated 2026-10-28
NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Sant Joan de Déu, Barcelona · Grupo Pedro Jaén, Madrid · Hospital Universitario 12 de Octubre, Madrid · CHUS - Hospital Clinico Universitario, Santiago de Compostela- A Coruna
Registry updated 2026-10-27
NCT04772079
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital General Universitario de Alicante, Alicante · Hospital Universitario de Cruces, Barakaldo · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-10-26
NCT07449702
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Trial Treatment · Phase 2 · Oruka Therapeutics, Inc.
Hospital Germans Trias i Pujol, Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Icr Medical S.L., Madrid · Hospital Universitario La Paz, Madrid
Registry updated 2026-10-23
NCT07683065
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Research · Novartis Pharmaceuticals
Novartis Investigative Site, Badalona · Novartis Investigative Site, Barcelona · Novartis Investigative Site, Madrid · Novartis Investigative Site, Málaga · Novartis Investigative Site, Valencia · Novartis Investigative Site, Zaragoza
Registry updated 2026-10-16
NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Trial Treatment · Phase 3 · Takeda
Hospital Universitario de Badajoz, Badajoz · Hospital Universitario Regional de Málaga, Málaga · Parc Tauli Hospital Universitari, Sabadell · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-14
NCT07039110
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Research · AbbVie
Hospital General Universitario Santa Maria Del Rosell /ID# 277894, Cartagena · Hospital Clinico Universitario Virgen de la Arrixaca /ID# 283338, El Palmar · Hospital Universitario de Leon /ID# 277895, León · Hospital Regional Universitario de Malaga /ID# 277220, Málaga · Hospital General Universitario Morales Meseguer /ID# 283339, Murcia · Complejo Hospitalario Universitario de Pontevedra /ID# 278085, Pontevedra · Hospital Universitario De Toledo /ID# 277896, Toledo
Registry updated 2026-10-01
NCT07849101
Ceramol PSOR Cream as an Adjuvant Treatment in Patients With Mild-to-Moderate Psoriasis Treated With Narrowband UVB Phototherapy (CERAMOL PSOR CREMA)
Trial Treatment · Unifarco SpA
Hospital Universitario Puerta de Hierro - Majadahonda, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-09-30
NCT04638647
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Trial Treatment · Phase 4 · Novartis Pharma AG
Hospital Universitario Basurto, Bilbao · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Parc Tauli Hospital Universitari, Sabadell · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-25
NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Trial Treatment · Phase 1 · UCB Biopharma SRL
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-09-18
NCT07250802
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Trial Treatment · Phase 3 · Takeda
Hospital General Universitario Dr. Balmis, Alicante · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-09-09
NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Trial Treatment · Phase 3 · Takeda
Accellacare Espana S.L., Alcobendas · Hospital Universitario de Badajoz, Badajoz · Hospital Universitario La Paz, Madrid · Hospital Universitario Regional de Málaga, Málaga · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario de Canarias, San Cristóbal de La Laguna · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Quironsalud Sagrado Corazon, Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Araba, Vitoria
Registry updated 2026-09-09
NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Trial Treatment · Phase 3 · AbbVie
Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-01
2023-505121-14-00
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Janssen - Cilag International
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario de Cruces, Barakaldo · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Clínico San Cecilio, Granada · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario 12 de Octubre, Madrid · Icr Medical S.L., Madrid · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-07-16
2025-521424-30-00
A Phase 3 Mechanistic Longitudinal Study to Evaluate the Impact of EARLY Risankizumab Treatment on TRM Cell Levels in Moderate-to-Severe Psoriasis
Trial Treatment · Phase 3 · Icr Medical S.L.
Icr Medical S.L., Madrid
Registry updated 2026-06-29
NCT07611747
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Trial Treatment · Phase 4 · Instituto de Investigación Marqués de Valdecilla
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital General Universitario de Ciudad Real, Ciudad Real · Hospital Universitario Reina Sofia, Córdoba · Hospital General Universitario de Elche, Elche · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario La Paz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Vega Baja de Orihuela, Orihuela · Hospital Son Llatzer, Palma · Hospital Universitario de Canarias, San Cristóbal de La Laguna · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario San Juan de Alicante, Sant Joan d'Alacant · Hospital Sierrallana, Torrelavega · Hospital Universitario Araba, Vitoria · Hospital laredo
Registry updated 2026-05-28
NCT06764693
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Research · AbbVie
Hospital Universitario Virgen de las Nieves /ID# 275741, Granada · Hospital Universitario Clinico San Cecilio /ID# 272665, Granada · Hospital Juan Ramón Jiménez /ID# 272667, Huelva · Hospital Rafael Mendez /ID# 272663, Lorca · Hospital Universitario La Paz /ID# 264316, Madrid · Hospital Universitario de La Princesa /ID# 264073, Madrid · Hospital Universitario 12 de Octubre /ID# 272660, Madrid · Hospital Universitario Virgen de la Victoria /ID# 264317, Málaga · Hospital General Universitario Reina Sofía /ID# 272664, Murcia · Hospital Universitario de Valme /ID# 264314, Seville · Hospital Xeral Cies (CHUVI) /ID# 272659, Vigo
Registry updated 2026-02-17

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error